Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
BioRestorative Therapies, Inc. (BRTX)
|
|
Cash Flow Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Sep-30-20 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q |
Net income | -3.0 | -4.7 | -4.7 | -4.8 | -4.2 | -4.1 | -15.7 | -0.8 |
Depreciation and amortization | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Stock-based compensation | 0.3 | 0.0 | 6.4 | 0.1 | | | | 0.2 |
Change in working capital [+] | | 0.1 | 0.3 | 0.1 | 0.3 | 0.0 | 0.3 | 0.1 |
Accounts receivable | | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other current assets | | 0.0 | 0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Accounts payable | | 0.1 | 0.2 | 0.2 | 0.0 | -0.1 | 0.1 | 0.1 |
Accrued expenses | | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.0 |
Other operating activities | | 3.1 | -3.3 | 3.1 | 3.3 | 3.3 | 14.5 | 0.0 |
Cash from operations | -2.7 | -1.5 | -1.3 | -1.6 | -0.6 | -0.7 | -0.8 | -0.5 |
|
Capital expenditures | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Purchases of property and equipment | | 0.0 | -0.1 | -0.1 | | | | |
Purchases of short-term investments | | -9.9 | | | | | | |
Purchases of short-term investments | | -9.9 | | | | | | |
Cash from investing | 0.0 | -9.9 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
|
Other cash from financing | | | | | | | 0.3 | 0.4 |
Cash from financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.4 |
|
Free cash flow | -2.7 | -1.4 | -1.4 | -1.7 | -0.6 | -0.7 | -0.8 | -0.5 |
Per share (diluted) | ($0.68) | ($0.39) | ($0.38) | ($0.48) | ($0.75) | ($0.93) | ($1.11) | ($1.31) |
|
|